68 related articles for article (PubMed ID: 7287412)
1. Heat inactivation of plasma hydrolases as a means of discriminating between the genotypes in cystic fibrosis: the experience in Israel.
Katznelson D; Sack J; Frass M; Vogt E; Hosli P
Isr J Med Sci; 1981 Aug; 17(8):687-9. PubMed ID: 7287412
[TBL] [Abstract][Full Text] [Related]
2. Detection of cystic fibrosis homozygotes and heterozygotes with plasma.
Hösli P; Vogt E
Lancet; 1979 Sep; 2(8142):543-5. PubMed ID: 89555
[TBL] [Abstract][Full Text] [Related]
3. Thermostability of alpha-mannosidase in plasma from cystic fibrosis patients and carriers.
Kohlschütter A; Jacobsen H
FEBS Lett; 1983 May; 155(2):223-4. PubMed ID: 6852234
[No Abstract] [Full Text] [Related]
4. Acid hydrolases in sera and plasma from patients with cystic fibrosis.
Hultberg B; Ceder O; Kollberg H
Clin Chim Acta; 1981 May; 112(2):167-75. PubMed ID: 6263520
[TBL] [Abstract][Full Text] [Related]
5. Plasma and submandibular saliva lysosomal enzymes in cystic fibrosis.
Oglesbee LH; Seale TW; Mayes JS; Flux M; Young SK; Renner OM
Clin Chim Acta; 1984 Nov; 143(2):135-45. PubMed ID: 6391740
[TBL] [Abstract][Full Text] [Related]
6. Fcgamma receptor IIA genotype and susceptibility to P. aeruginosa infection in patients with cystic fibrosis.
De Rose V; Arduino C; Cappello N; Piana R; Salmin P; Bardessono M; Goia M; Padoan R; Bignamini E; Costantini D; Pizzamiglio G; Bennato V; Colombo C; Giunta A; Piazza A
Eur J Hum Genet; 2005 Jan; 13(1):96-101. PubMed ID: 15367919
[TBL] [Abstract][Full Text] [Related]
7. Heat inactivation of plasma hydrolases in cystic fibrosis.
Sack J; Katznelson D; Frass M; Stur OB
Lancet; 1980 Aug; 2(8188):268. PubMed ID: 6105433
[No Abstract] [Full Text] [Related]
8. High degree of satellite association and decreased nucleolar organizer activity in cystic fibrosis subjects.
Ravia Y; Lieberman I; Ravé A; Kremer M; Avivi L
Am J Med Genet; 1987 Nov; 28(3):593-605. PubMed ID: 3425629
[TBL] [Abstract][Full Text] [Related]
9. Lymphocytic acid-hydrolases and response to mitogens in cystic fibrosis.
Lieberman J; Kaneshiro W
Chest; 1979 Feb; 75(2 Suppl):220-3. PubMed ID: 108048
[No Abstract] [Full Text] [Related]
10. Cystic fibrosis carrier frequencies in populations of African origin.
Padoa C; Goldman A; Jenkins T; Ramsay M
J Med Genet; 1999 Jan; 36(1):41-4. PubMed ID: 9950364
[TBL] [Abstract][Full Text] [Related]
11. The changing face of the exocrine pancreas in cystic fibrosis: the correlation between pancreatic status, pancreatitis and cystic fibrosis genotype.
Augarten A; Ben Tov A; Madgar I; Barak A; Akons H; Laufer J; Efrati O; Aviram M; Bentur L; Blau H; Paret G; Wilschanski M; Kerem BS; Yahav Y
Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):164-8. PubMed ID: 18301294
[TBL] [Abstract][Full Text] [Related]
12. Pancreatitis among patients with cystic fibrosis: correlation with pancreatic status and genotype.
De Boeck K; Weren M; Proesmans M; Kerem E
Pediatrics; 2005 Apr; 115(4):e463-9. PubMed ID: 15772171
[TBL] [Abstract][Full Text] [Related]
13. Increased risk of idiopathic chronic pancreatitis in cystic fibrosis carriers.
Cohn JA; Neoptolemos JP; Feng J; Yan J; Jiang Z; Greenhalf W; McFaul C; Mountford R; Sommer SS
Hum Mutat; 2005 Oct; 26(4):303-7. PubMed ID: 16134171
[TBL] [Abstract][Full Text] [Related]
14. Does cystic fibrosis neonatal screening detect atypical CF forms? Extended genetic characterization and 4-year clinical follow-up.
Narzi L; Ferraguti G; Stamato A; Narzi F; Valentini SB; Lelli A; Delaroche I; Lucarelli M; Strom R; Quattrucci S
Clin Genet; 2007 Jul; 72(1):39-46. PubMed ID: 17594398
[TBL] [Abstract][Full Text] [Related]
15. Detection of cystic fibrosis with plasma hydrolases.
Harris A; Benson PF; Fensom AH
Lancet; 1979 Dec 22-29; 2(8156-8157):1371. PubMed ID: 92712
[No Abstract] [Full Text] [Related]
16. [Relation between gene mutations and pancreatic exocrine function in patients with cystic fibrosis].
Radivojević D; Guć-Sćekić M; Djurisić M; Lalić T; Minić P; Kanavakis E
Srp Arh Celok Lek; 2001; 129 Suppl 1():6-9. PubMed ID: 15637983
[TBL] [Abstract][Full Text] [Related]
17. [Cystic fibrosis: molecular genetics and new perspectives of prevention and therapy].
Garnerone S; Restagno G; Santini B; Carbonara A
Ann Ital Med Int; 1994; 9(2):67-73. PubMed ID: 7917764
[TBL] [Abstract][Full Text] [Related]
18. [Identification of mutation in the gene cystic fibrosis transmembrane regulator (CFTR) in Chilean patients with cystic fibrosis].
Repetto G; Poggi H; Harris P; Navarro H; Sánchez I; Guiraldes E; Pérez MA; Boza ML; Hunter B; Wevar ME; Mediavilla M; Foradori A
Rev Med Chil; 2001 Aug; 129(8):841-7. PubMed ID: 11680956
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of cystic fibrosis homozygotes and heterozygotes from plasma and fibroblast cultures. A three-generation family study.
Ceder O; Hösli P; Vogt E; Kollberg H
Clin Genet; 1983 Apr; 23(4):298-303. PubMed ID: 6221836
[TBL] [Abstract][Full Text] [Related]
20. Frequency and clinical significance of the S1235R mutation in the cystic fibrosis transmembrane conductance regulator gene: results from a collaborative study.
Monaghan KG; Feldman GL; Barbarotto GM; Manji S; Desai TK; Snow K
Am J Med Genet; 2000 Dec; 95(4):361-5. PubMed ID: 11186891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
